In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores the data and recommendations for HIV postexposure prophylaxis (PEP).Listen as she gives perspectives on:The CDC algorithm for evaluation and treatment of potential HIV exposuresThe CDC guideline preferred and alternative PEP antiretroviral therapy regimensData for the use of the single-tablet regimen bictegravir/emtricitabine/tenofovir alafenamide for PEPRecommended laboratory monitoring with PEPThe initiation of pre-exposure prophylaxis following a course of PEP, when appropriatePresenter:Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVSAssistant Professor of PediatricsDivision of Pediatric Infectious DiseasesPediatric and Adolescent HIV Children’s Hospital at MontefiorePediatric Hospital of Albert Einstein College of MedicineBronx, New York Follow along with the slides at:https://bit.ly/3NBVXWNSee the entire program at:https://bit.ly/3fOl0XX